Jacobio Pharma announced it has entered into a clinical collaboration with Merck & Co., Inc., Rahway, NJ, USA to evaluate the combination of Jacobio's CD73 monoclonal antibody JAB-BX102

The 2023 Annual Meeting of American Academy of Dermatology Association was held from 17 to 21 March 2023 in New Orleans, Louisiana, United States. As one of the largest, most influential

Stevanato Group S.p.A. a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced

Labstat Inc., A Certified Group Company, has entered into a partnership with Toxys to offer the ToxTracker assay at its Kitchener, Ontario laboratory. ToxTracker is a state-of-the-art stem

DelSiTech Ltd, a Finnish drug delivery and drug development company, today announces that it has been awarded a grant from the Bill & Melinda Gates Foundation to develop

Nippon Express a group company of NIPPON EXPRESS HOLDINGS, INC., became the first Japanese forwarder to join Pharma.Aero on January 25 this year.

Optimism is on the rise as the American Cancer Society is reporting that the five-year survival rate for those diagnosed with pancreatic has increased to 12%—representing an increase of 1% over

Astellas Pharma Inc. today announced positive topline results from the Phase 3 China ARCHES study of XTANDI® plus androgen deprivation therapy in men with metastatic hormone-sensitive

On March 7th, 2023, Suzhou Porton Advanced Solutions Ltd. and Bennu Biotherapeutics announced a strategic partnership to advance cell and gene therapy R&D pipelines.

Sumitovant Biopharma Ltd.and Myovant Sciences Ltd. announced today that Sumitovant has successfully completed its acquisition of Myovant originally announced October 23, 2022.